Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research
NCT00341042 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 253
Last updated 2018-04-05
Summary
This study, conducted in Bamako, Mali (West Africa), will collect blood and sputum samples to establish normal values for laboratory test results among Malians. Researchers are starting a new initiative to study HIV and tuberculosis in Africa, using Mali as a model country. In order to perform these studies, the scientists need to know what constitutes normal laboratory values among the population. People in developing countries may have dramatically different laboratory values from those who live in developed countries, and there is currently little information available to distinguish normal from abnormal results in Malians. This study will establish normal ranges that will provide a basis for future HIV and tuberculosis research in Mali. Additionally it will provide blood and sputum samples to researchers to study different scientific questions related to HIV and Tuberculosis infection.
Healthy volunteers and people infected with HIV or tuberculosis, or both, who are 18 years of age or older and who live in Bamako, Mali, may be eligible for this study. Candidates are screened with a medical history, physical examination, and blood test.
Participants provide a blood or sputum sample, or both, for laboratory analysis. Blood is collected through a needle inserted into an arm vein, and sputum is collected by having the participant cough deeply and spit in a cup. Participants may agree to provide samples one time only or on a returning visit basis. Returning visits may be scheduled daily or weekly. Subjects may continue to participate for the duration of the 4-year study, provided their medical history and physical examination are updated once a year.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Sophia B Siddiqui, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-01-04
- Completion
- 2013-05-01
Countries
- Mali
Study Locations
More Related Trials
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
NCT04926922 ·Status: COMPLETED
-
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
NCT01433796 ·Status: COMPLETED
-
POC Strategies to Improve TB Care in Advanced HIV Disease
NCT04122404 ·Status: COMPLETED ·Phase: NA
-
Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
NCT01417988 ·Status: TERMINATED ·Phase: PHASE4
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
Nutrition, Diabetes and Pulmonary TB/HIV
NCT00311298 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa
NCT03711721 ·Status: COMPLETED ·Phase: NA
-
HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease
NCT01141205 ·Status: COMPLETED ·Phase: PHASE1
-
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
NCT03610802 ·Status: RECRUITING
-
Important Data on COVID-19 Profile in Africa
NCT04847817 ·Status: COMPLETED
-
Gene Expression in HIV and Tuberculosis Co-infection
NCT01611402 ·Status: COMPLETED
-
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV
NCT03154320 ·Status: COMPLETED ·Phase: NA
-
Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis
NCT05452616 ·Status: COMPLETED ·Phase: NA
-
Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa
NCT00346476 ·Status: COMPLETED
-
Examining HIV Treatment Adherence During Early Disease
NCT02419066 ·Status: COMPLETED
-
Determining Bacterial Communities in the Lungs of HIV-infected Individuals With COPD in Uganda.
NCT04070248 ·Status: UNKNOWN
-
Interrupting HIV and TB Stigma in the Household in Uganda
NCT05124665 ·Status: COMPLETED ·Phase: NA
-
TB-CAPT EXULTANT - HIV
NCT04568967 ·Status: COMPLETED ·Phase: NA
-
Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
NCT00604617 ·Status: COMPLETED
-
Test and Treat TB: A Proof of Concept Trial in South Africa
NCT02298309 ·Status: COMPLETED ·Phase: NA
-
Gathering Records to Evaluate Antiretroviral Treatment-Malawi ( GREAT )
NCT04158895 ·Status: RECRUITING
-
Gathering Records to Evaluate Antiretroviral Treatment-South Africa
NCT04149782 ·Status: RECRUITING
-
Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
NCT05268380 ·Status: COMPLETED
-
HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes
NCT06671808 ·Status: COMPLETED
-
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 ·Status: COMPLETED ·Phase: PHASE3